Cargando…

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review

BACKGROUND: Several quinoline and structurally related antimalarial drugs are associated with cardiovascular side effects, particularly hypotension and electrocardiographic QT interval prolongation. A prolonged QT interval is a sensitive but not specific risk marker for the development of Torsade de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haeusler, Ilsa L., Chan, Xin Hui S., Guérin, Philippe J., White, Nicholas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220451/ https://www.ncbi.nlm.nih.gov/pubmed/30400791 http://dx.doi.org/10.1186/s12916-018-1188-2

Ejemplares similares

The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis
por: Chan, Xin Hui S., et al.
Publicado: (2021)

Structural modifications of quinoline-based antimalarial agents: Recent developments
por: Bawa, Sandhya, et al.
Publicado: (2010)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Quinoline-Based Hybrid Compounds with Antimalarial Activity
por: Nqoro, Xhamla, et al.
Publicado: (2017)

Quinoline Antimalarials Increase the Antibacterial Activity of Ampicillin
por: Olateju, Olajumoke A., et al.
Publicado: (2021)

Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders
por: Sherazi, Saadia, et al.
Publicado: (2023)

The threat of antimalarial drug resistance
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016)

The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials
por: Vallières, Cindy, et al.
Publicado: (2017)

A Review of Modifications of Quinoline Antimalarials: Mefloquine and (hydroxy)Chloroquine
por: Kucharski, Dawid J., et al.
Publicado: (2022)

Trends in Antimalarial Drug Use in Africa
por: Flegg, Jennifer A., et al.
Publicado: (2013)

The assessment of antimalarial drug efficacy in-vivo
por: White, Nicholas J.
Publicado: (2022)

Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats
por: Pourkhalili, Khalil, et al.
Publicado: (2015)

Benefits of a Pharmacology Antimalarial Reference Standard and Proficiency Testing Program Provided by the Worldwide Antimalarial Resistance Network (WWARN)
por: Lourens, Chris, et al.
Publicado: (2014)

Synthesis and antimalarial potential of some novel quinoline-pyrazolopyridine derivatives
por: Saini, Deepika, et al.
Publicado: (2016)

Mode of action of quinoline antimalarial drugs in red blood cells infected by Plasmodium falciparum revealed in vivo
por: Kapishnikov, Sergey, et al.
Publicado: (2019)

New Potential Antimalarial Agents: Design, Synthesis and Biological Evaluation of Some Novel Quinoline Derivatives as Antimalarial Agents
por: Radini, Ibrahim Ali M., et al.
Publicado: (2016)

Heterologous Expression of a Novel Drug Transporter from the Malaria Parasite Alters Resistance to Quinoline Antimalarials
por: Tindall, Sarah M., et al.
Publicado: (2018)

How antimalarial drug resistance affects post-treatment prophylaxis
por: White, Nicholas J
Publicado: (2008)

Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases
por: Herraiz, Tomás, et al.
Publicado: (2019)

Ethics and Antimalarial Drug Resistance
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)

Interference with Hemozoin Formation Represents an Important Mechanism of Schistosomicidal Action of Antimalarial Quinoline Methanols
por: Corrêa Soares, Juliana B. R., et al.
Publicado: (2009)

Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs
por: Chairat, Kalayanee, et al.
Publicado: (2018)

Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications
por: Firestone, Tessa M., et al.
Publicado: (2021)

Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
por: Stepniewska, Kasia, et al.
Publicado: (2006)

Antimalarial mass drug administration in large populations and the evolution of drug resistance
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
por: Lourens, Chris, et al.
Publicado: (2010)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
por: White, Nicholas J.
Publicado: (2013)

Characterizing Blood-Stage Antimalarial Drug MIC Values In Vivo Using Reinfection Patterns
por: Watson, James, et al.
Publicado: (2018)

Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study
por: Dahal, Prabin, et al.
Publicado: (2019)

Surveillance of Travellers: An Additional Tool for Tracking Antimalarial Drug Resistance in Endemic Countries
por: Gharbi, Myriam, et al.
Publicado: (2013)

In Silico Mining for Antimalarial Structure-Activity Knowledge and Discovery of Novel Antimalarial Curcuminoids
por: Viira, Birgit, et al.
Publicado: (2016)

Repurposing antimalarials and other drugs for COVID-19
por: Schlagenhauf, Patricia, et al.
Publicado: (2020)

Drug resistance genomics of the antimalarial drug artemisinin
por: Winzeler, Elizabeth A, et al.
Publicado: (2014)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Counterfeit artesunate antimalarials in southeast Asia
por: Newton, Paul N, et al.
Publicado: (2003)

World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
por: Bacon, David J, et al.
Publicado: (2007)

Comparing Highly Efficacious Antimalarial Drugs
por: Sutherland, Colin J
Publicado: (2008)

Revisiting the Design of Phase III Clinical Trials of Antimalarial Drugs for Uncomplicated Plasmodium falciparum Malaria
por: Borrmann, Steffen, et al.
Publicado: (2008)

Quality of Antimalarial Drugs in East Africa: A Systematic Review
por: Girma, Million, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ebsutaico8ehl7frqqji2kfn3o